Skip to main content
Clinical Trials/NL-OMON40337
NL-OMON40337
Completed
Not Applicable

A case-cohort study to identify risk factors for cardiovascular disease in testicular cancer survivors - TACkLE-study - Tackling Adverse Chemotherapy-associated Late Effects

niversitair Medisch Centrum Groningen0 sites900 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
hartfalen, metabool syndroom
Sponsor
niversitair Medisch Centrum Groningen
Enrollment
900
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\) All invited patients have to meet the following criteria:
  • \-TC diagnosis between 01\-01\-1976 to 31\-12\-2007
  • \-TC treatment center: UMCG, NKI/AVL, Erasmus MC, UMCN, LUMC
  • \-Younger than 50 years of age at TC diagnosis;2A) Cases have to fulfill, beside the aforementioned criteria, the following criteria:
  • \-Diagnosed with either myocardial infarction (MI), proven coronary artery disease (CAD) (CTCAE\-4 grade 2 or higher) or congestive heart failure (CHF) (CTCAE\-4 grade 2 or higher).
  • \-No medical history of CVD before diagnosis of TC;2B) In order to be eligible to participate in the cardiometabolic risk inventory study (and to be invited to a study assessment), a subject must meet, next to the criteria mentioned in \*1\)\*, the following inclusion criteria:
  • Cases and member of subcohort:
  • \-Younger than 40 years of age at TC diagnosis
  • \-Younger than 75 years of age at moment of inclusion
  • \-Written informed consent

Exclusion Criteria

  • \- Mental disorder (no informed consent available)
  • \- Presence of active malignant disease

Outcomes

Primary Outcomes

Not specified

Similar Trials